Activation of platelets in bronchial asthma

Chest

Volumn 113, Issue 2, 1998, Pages 452-458

  Moritani, Chie ^a   Ishioka, Shinichi ^a   Haruta, Yoshinori ^a   Kambe, Masayuki ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma, CD62P; Intracellular free calcium concentration; Platelet; RANTES; Theophylline

Indexed keywords

9,11 EPITHIO 11,12 METHANOTHROMBOXANE A2; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CHEMOKINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; PADGEM PROTEIN; RANTES; THEOPHYLLINE; THROMBIN;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0031910794     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.2.452     Document Type: Article

References (42)

1. Barnes PJ. New aspects of asthma. J Intern Med 1992; 231:453-61
2. Herd CM, Page CP. Pulmonary immune cells in health and disease: platelets. Eur Respir J 1994; 7:1145-60
3. Klinger MH, Wilhelm D, Bubel S, et al. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy immunol 1995; 107:541-46
4. Kameyoshi Y, Dörchner A, Mallet AI, et al. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176:587-92
5. Kameyoshi Y, Schröder JM, Christopher E, et al. Identification of the cytokine RANTES released from platelets as an eosinophil chemotactic factor. Int Arch Allergy Immunol 1994; 104(suppl 1):49-51
6. Szczeklik A, Milner PC, Birch J, et al. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb Haemost 1986; 56:283-87
7. Taytard A, Guenard H, Vuillemin L, et al. Platelets kinetics in stable atopic asthmatic patients. Am Rev Respir Dis 1986; 134:983-85
8. Audera C, Rocklin R, Vaillancourt R, et al. Altered arachidonic acid metabolism and platelet size in atopic subjects. Clin Immunol Immunopathol 1988; 46:352-59
9. Gresele P, Dottorini M, Selli ML, et al. Altered platelet function associated with bronchial hyperresponsiveness accompanying nocturnal asthma. J Allergy Clin Immunol 1993; 91:894-902
10. Maccia CA, Gallagher JS, Ataman G, et al. Platelet thrombopathy in asthmatic patients with elevated immunoglobulin E. J Allergy Clin Immunol 1997; 59:101-08
11. Gresele P, Ribaldi E, Grasselli S, et al. Evidence for platelet activation in allergic asthma. In: Schmitz-Schuman M, Menz G, Page CP, eds. PAF, platelets, and asthma: Agents and Actions (suppl 21). Basal: Brikhauser Verlag, 1987; 119-28
12. Yamamoto H, Nagata M, Tabe K, et al. The evidence of platelet activation in bronchial asthma. J Allergy Clin Immunol 1993; 91:80-87
13. Averill FJ, Hubbard WC, Proud D, et al. Platelet activation in the lung after antigen challenge in a model of allergic asthma. Am Rev Respir Dis 1992; 145:571-76
14. Beasley R, Roche WR, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17
15. Metzger WJ, Sjoerdsma K, Richerson HB, et al. Platelets in bronchoalveolar lavage from asthmatic patients and allergic rabbits with allergen-induced late phase responses. In: Schmitz-Schuman M, Menz G, Page CP, eds. PAF, platelets, and asthma: Agents and Actions (suppl 21). Basal: Brikhauser Verlag, 1987; 151-59
16. Martin JF, Slater DN, Trowbridge EA. Platelet production in the lungs. In: Schmitz-Schuman M, Menz G, Page CP, eds. PAF, platelets, and asthma: Agents and Actions (suppl 21). Basal: Brikhauser Verlag, 1987; 37-57
17. Abrams CS, Ellison N, Budzynski AZ, et al. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75:128-38
18. Oshima T, Young EW, Bukoski RD, et al. Abnormal calcium handling by platelets of spontaneously hypertensive rats. Hypertension 1990; 15:606-11
19. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1995; 260:3440-50
20. Hozawa S, Haruta Y, Ishioka S, et al. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am J Respir Crit Care Med 1995; 152:1198-202
21. Heemskerk JWM, Sage SO. Platelets: calcium signaling in platelets and other cells. 5th ed. Essex: Longman Group Ltd, 1994; 295-316
22. Lapetina EG. The signal transduction induced by thrombin in human platelets. FEBS Lett 1990; 268:400-04
23. Manning DR, Brass LF. The role of GTP-binding proteins in platelet activation. Thromb Haemost 1991; 66:393-99
24. Block LH, Imhof E, Emmons LR, et al. PAF-dependent phosphatidylinositol turnover in platelets: differences between asthmatics and normal individuals. Respiration 1990; 57:372-78
25. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 69:58-178
26. Murphy CT, Westwick J. Selective inhibition of protein kinase C. Biochem J 1992; 283:159-64
27. Werner MH, Bielawska AE, Hannun YA. Multiphasic generation of diacylglycerol in thrombin-activated human platelets. Biochem J 1992; 282:815-20
28. 2 analogues in human platelets. J Biol Chem 1990; 265:6836-44
29. Oda A, Daley JF, Kang J, et al. Quasi-simultaneous measurement of ionized calcium and α-granule release in individual platelets. Am J Physiol 1991; 260:C242-48
30. 2+], in exocytosis and transbilayer movement in human platelets surface-labeled with the fluorescent probe 1-(4 (trimethylammonio)phenyl)-6-phenyl-1,3,5-hexatriene. Biochim Biophys Acta 1993; 1147:194-204
31. 2+ and protein kinase C is the major factor in determining the level of secretion from human platelets. Biochem J 1993; 289:277-82
32. 2+ stores. Biochem J 1991; 280:783-89
33. 2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry. Cell Calcium 1992; 13:553-64
34. Sage SO, Rink TJ. The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets. J Biol Chem 1987; 262:16364-69
35. Eigenthaler M, Nolte C, Halbrügge M, et al. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets: estimating the ratio of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur J Biochem 1992; 205:471-81
36. Watson SP, McConnell RT, Lapetina EG. The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J Biol Chem 1984; 259:13199-203
37. Durante W, Kroll MH, Vanhoutte PM, et al. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting phospholipase C. Blood 1992; 79: 110-16
38. Yada Y, Nagao S, Okano Y, et al. Inhibition by cyclic AMP of guanine nucleotide-induced activation of phosphoinositide-specific phospholipase C in human platelets. FEBS Lett 1989; 242:368-72
39. 2+ release from platelet membranes. Biochim Biophys Res Commun 1992; 184:893-99
40. Johansson JS, Haynes DH. Cyclic GMP increases the rate of the calcium extrusion pump in intact human platelets but has no direct effect on the dense tubular calcium accumulation system. Biochim Biophys Acta 1992; 1105:40-50
41. Sullivan P, Bekir S, Jaffar Z, et al. Anti-inflammatory effects of low dose oral theophylline in atopic asthma. Lancet 1994; 343:1006-08
42. Jenne JW. Two new roles for theophylline in the asthmatic? J Asthma 1995; 32:89-95